-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3

Benzinga·08/13/2026 16:43:09
语音播报
Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.